Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine

被引:38
作者
Ootsuka, Y [1 ]
Nalivaiko, E [1 ]
Blessing, WW [1 ]
机构
[1] Flinders Univ S Australia, Dept Human Physiol, Bedford Pk, SA 5042, Australia
基金
英国医学研究理事会;
关键词
cutaneous blood flow; SR; 4634913; medullary raphe; serotonin; DOI; sympathetic preganglionic neurons;
D O I
10.1016/j.brainres.2004.03.058
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We determined whether spinal 5-hydroxytryptamine 2A (5-HT2A) receptors contribute to resting cutaneous sympathetic vasomotor activity, and to increases in activity elicited by electrical stimulation of the medullary raphe/parapyramidal region, and whether these receptors are involved in the cutaneous vasoconstricting action of systemically administered MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine. Experiments were conducted in urethane-anesthetized rabbits and rats. Administration of the 5-HT2A antagonist, trans-4-((3Z)3-[(2-Dimethylaminoethyl)oxyimino]-3-(2-fluorophenyl)propen-1-yl)-phenol, hemifumarate (SR 4634913, 0.1 mg/kg, i.v.) inhibited resting car pinna sympathetic vasomotor nerve discharge and reduced the extent to which raphe/parapyramidal electrical stimulation caused ear pinna (rabbit) and tail (rat) artery blood flow to fall. Clozapine (0.125-0.5 mg/kg, i.v.) also reduced the fall in ear pinna blood flow elicited by raphe/parapyramidal stimulation. In rabbits, after inactivation of raphe/parapyramidal function by local microinjection of muscimol (1 nmol in 100 nl), the 5-HT2A agonist R(-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI, 50 mug/kg, i.v.) increased ear pinna sympathetic nerve activity from 3 +/- 2% to 129 +/- 5% of pre-muscimol levels (P < 0.01, it - 6), and this increase was abolished by section of the ipsilateral cervical sympathetic nerve trunk. MDMA (2 mg/kg, i.v.) after muscimol decreased car pinna blood flow from 33 +/- 10 to 2 +/- 1 cm/s (P < 0.01, n = 5) and increased ear pinna sympathetic nerve activity from 8 +/- 4% to 120 +/- 41% of pre-muscimol levels (P < 0.01, n = 6). The MDMA-elicited increase in nerve activity was abolished by SR 46349B. Data suggest that spinal 5-HT2A receptors contribute to sympathetically induced cutaneous vasoconstriction regulated by raphe/parapyramidal neurons in the brainstem, and that these receptors contribute to the cutaneous vasoconstricting action of MDMA and its reversal by clozapine. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:34 / 44
页数:11
相关论文
共 28 条
[1]   Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence [J].
Arnt, J ;
Skarsfeldt, T .
NEUROPSYCHOPHARMACOLOGY, 1998, 18 (02) :63-101
[2]   5-hydroxytryptamine2A receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats [J].
Blessing, WW ;
Seaman, B .
NEUROSCIENCE, 2003, 117 (04) :939-948
[3]   Regional blood flow and nociceptive stimuli in rabbits: patterning by medullary raphe, not ventrolateral medulla [J].
Blessing, WW ;
Nalivaiko, E .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 524 (01) :279-292
[4]  
Blessing WW, 2003, J NEUROSCI, V23, P6385
[5]   Raphe magnus/pallidus neurons regulate tail but not mesenteric arterial blood flow in rats [J].
Blessing, WW ;
Nalivaiko, E .
NEUROSCIENCE, 2001, 105 (04) :923-929
[6]   THE RESPONSE OF INDIVIDUAL SYMPATHETIC PREGANGLIONIC NEURONS TO MICROELECTROPHORETICALLY APPLIED ENDOGENOUS MONOAMINES [J].
COOTE, JH ;
MACLEOD, VH ;
FLEETWOODWALKER, S ;
GILBEY, MP .
BRAIN RESEARCH, 1981, 215 (1-2) :135-145
[7]  
Cornea-Hébert V, 1999, J COMP NEUROL, V409, P187, DOI 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO
[8]  
2-P
[9]   Tail artery blood flow measured by chronically implanted Doppler ultrasonic probes in unrestrained conscious rats [J].
Garcia, JN ;
Pedersen, NP ;
Nalivaiko, E ;
Blessing, WW .
JOURNAL OF NEUROSCIENCE METHODS, 2001, 104 (02) :209-213
[10]   The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") [J].
Green, AR ;
Mechan, AO ;
Elliott, JM ;
O'Shea, E ;
Colado, MI .
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :463-508